DOJ Rejects Novo Nordisk’s Claim CMS Illegally Counts 6 Drugs As 1 Under IRA

By Gabrielle Wanneh / January 30, 2024 at 3:00 PM
In a brief filed with a federal district court in Delaware Friday (Jan. 26), the government stood its ground against claims by Novo Nordisk that CMS is imposing Medicare drug price negotiation on more drugs than Congress authorized in the Inflation Reduction Act (IRA). The brief comes as CMS is expected to submit its first offer of lower prices for 10 selected Part D drugs by Thursday (Feb. 1), and as nine active lawsuits remain in play challenging the new...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.